Overview
X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome, also known as Brunner syndrome, is a rare genetic condition caused by mutations in the MAOA gene located on the X chromosome. This gene encodes monoamine oxidase A, an enzyme critical for the breakdown of neurotransmitters including serotonin, norepinephrine, and dopamine. When this enzyme is deficient or absent, these monoamines accumulate abnormally in the body, leading to neurological and behavioral disturbances. The syndrome primarily affects the central nervous system and is characterized by mild to borderline intellectual disability combined with prominent behavioral abnormalities. Key behavioral features include impulsive aggression, violent outbursts, arson, attempted rape, and other antisocial behaviors. Affected individuals may also exhibit sleep disturbances, night terrors, and stereotyped hand movements such as hand wringing or plucking. The condition predominantly affects males due to its X-linked recessive inheritance pattern, while carrier females are generally unaffected or mildly affected. Diagnosis is supported by biochemical findings showing markedly elevated urinary levels of monoamines and their metabolites, particularly elevated levels of serotonin, and can be confirmed through molecular genetic testing of the MAOA gene. There is currently no specific cure for this condition. Management is primarily supportive and symptomatic, focusing on behavioral interventions, structured environments, and in some cases pharmacological management of aggression and impulsivity. Genetic counseling is recommended for affected families.
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.
Community
No community posts yet. Be the first to share your experience with X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.
Start the conversation →Latest news about X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome
No recent news articles for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome
What is X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome?
X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome, also known as Brunner syndrome, is a rare genetic condition caused by mutations in the MAOA gene located on the X chromosome. This gene encodes monoamine oxidase A, an enzyme critical for the breakdown of neurotransmitters including serotonin, norepinephrine, and dopamine. When this enzyme is deficient or absent, these monoamines accumulate abnormally in the body, leading to neurological and behavioral disturbances. The syndrome primarily affects the central nervous system and is characterized by mild to borderl
How is X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome inherited?
X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome typically begin?
Typical onset of X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome is childhood. Age of onset can vary across affected individuals.